beta-D-Glcp-(1->3)-beta-D-Glcp-(1->4)-beta-D-Galp

Term ID

CHEBI:146744

Synonyms

(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
beta-D-gluco-hexopyranosyl-(1->3)-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-galacto-hexopyranose
beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranose
Glc(b1-3)Glc(b1-4)b-Gal

Definition

A trisaccharide consisting of two β-D-glucopyranosyl groups and a β-D-galactopyranosyl groupjoined in sequence by (1→3) and (1→4) glycosidic bonds.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Glcp-(1->3)-beta-D-Glcp-(1->4)-beta-D-Galp

Phenotype where environments contain beta-D-Glcp-(1->3)-beta-D-Glcp-(1->4)-beta-D-Galp

Phenotype modified by environments containing beta-D-Glcp-(1->3)-beta-D-Glcp-(1->4)-beta-D-Galp

Phenotype affecting beta-D-Glcp-(1->3)-beta-D-Glcp-(1->4)-beta-D-Galp

Human Disease Model